Switzerland High Potency Active Pharmaceutical Ingredients Market Size & Outlook
Switzerland high potency active pharmaceutical ingredients market, 2018-2030 (US$M)
Related Markets
Switzerland high potency active pharmaceutical ingredients market highlights
- The Switzerland high potency active pharmaceutical ingredients market generated a revenue of USD 273.5 million in 2023 and is expected to reach USD 560.9 million by 2030.
- The Switzerland market is expected to grow at a CAGR of 10.8% from 2024 to 2030.
- In terms of segment, synthetic was the largest revenue generating product in 2023.
- Biotech is the most lucrative product segment registering the fastest growth during the forecast period.
High potency active pharmaceutical ingredients market data book summary
| Market revenue in 2023 | USD 273.5 million |
| Market revenue in 2030 | USD 560.9 million |
| Growth rate | 10.8% (CAGR from 2023 to 2030) |
| Largest segment | Synthetic |
| Fastest growing segment | Biotech |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Synthetic, Biotech |
| Key market players worldwide | Basf SE, CordenPharma, Bristol-Myers Squibb Co, Pfizer Inc, Boehringer Ingelheim Pharma, Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Albany Molecular Research, Sanofi SA, Lonza Group Ltd, Cipla Ltd DR, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Novartis AG ADR, Roche Holding AG |
Other key industry trends
- In terms of revenue, Switzerland accounted for 1.0% of the global high potency active pharmaceutical ingredients market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany high potency active pharmaceutical ingredients market is projected to lead the regional market in terms of revenue in 2030.
- Russia is the fastest growing regional market in Europe and is projected to reach USD 682.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
High Potency Active Pharmaceutical Ingredients Market Scope
High Potency Active Pharmaceutical Ingredients Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Switzerland high potency active pharmaceutical ingredients market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to high potency active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 71.52% in 2023. Horizon Databook has segmented the Switzerland high potency active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Switzerland has a centralized and universal healthcare system, which is regulated by Swiss Federal Law. It has one of the best healthcare systems in the world owing to mandatory private insurance by the government. Switzerland has the highest rate of melanoma in the entire European region.
There are over 56,506 new cancer cases annually, which is expected to boost the demand for high potency oncology medications. Key players such as F. Hoffmann-La Roche AG, Lonza Group, and Novartis AG are based in Switzerland.
In 2019, Cerbios-Pharma SA announced that it is investing USD 5.5 million in its large-scale production line for HPAPI owing to the rising demand for HPAPI. Increasing investments along with growing demand for HPAPI are among factors anticipated to fuel the growth of the market.
Reasons to subscribe to Switzerland high potency active pharmaceutical ingredients market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Switzerland high potency active pharmaceutical ingredients market databook
-
Our clientele includes a mix of high potency active pharmaceutical ingredients market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Switzerland high potency active pharmaceutical ingredients market , including forecasts for subscribers. This country databook contains high-level insights into Switzerland high potency active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Switzerland high potency active pharmaceutical ingredients market size, by product, 2018-2030 (US$M)
Switzerland High Potency Active Pharmaceutical Ingredients Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
